Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Panacea Acquisition Corp II Cl A (PANA)

Panacea Acquisition Corp II Cl A (PANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 241,101
  • Shares Outstanding, K 23,545
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,430 K
  • 60-Month Beta 0.00
  • Price/Sales N/A
  • Price/Cash Flow 168.84
  • Price/Book N/A
Trade PANA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.17 +0.69%
on 03/21/23
10.92 -6.23%
on 04/14/23
+0.08 (+0.79%)
since 03/17/23
3-Month
10.04 +1.99%
on 02/13/23
10.92 -6.23%
on 04/14/23
+0.17 (+1.69%)
since 01/18/23
52-Week
9.69 +5.68%
on 07/12/22
10.92 -6.23%
on 04/14/23
+0.49 (+5.03%)
since 04/08/22

Most Recent Stories

More News
Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering

SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition,...

PANA : 10.24 (-0.10%)
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333-250036) (as amended, the “Registration...

PANA : 10.24 (-0.10%)
SPACs Surge as Biotech Booms

NetworkNewsWire Editorial Coverage : As the world has focused on the search for COVID vaccines and therapeutics, biotech IPOs have quietly  gone bonkers . As a matter of fact, 2020 is on track to post...

GILD : 67.08 (+0.07%)
KBLM : 4.99 (-17.52%)
LLY : 732.20 (-1.81%)
MRK : 127.00 (+0.09%)
RETA : 172.36 (+0.02%)
PANA : 10.24 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar